C2CD6: A Potential Drug Target and Biomarker (G151254)

Target Name: C2CD6

NCBI ID: G151254

C2CD6: A Potential Drug Target and Biomarker

C2CD6 is a protein that is expressed in various tissues and cell types in the body. Its full name is catSper-tau, which is a type of transmembrane protein that is characterized by its unique structure and its ability to interact with various signaling pathways. C2CD6 has been shown to play a role in a variety of physiological processes, including cell signaling, tissue repair, and inflammation. As a result, C2CD6 has potential as a drug target and biomarker.

The Druggable Potential of C2CD6

C2CD6 has been identified as a potential drug target due to its unique structure and its involvement in various signaling pathways. The protein is involved in several signaling pathways that are crucial for cell survival and growth, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are involved in a variety of cellular processes, including cell signaling, cell adhesion, angiogenesis, and inflammation. As a result, blocking or modulating the activity of C2CD6 may have a wide range of potential therapeutic applications.

In addition to its involvement in signaling pathways, C2CD6 has also been shown to play a role in the regulation of cellular processes that are important for tissue repair and regeneration. The protein has been shown to be involved in the regulation of cell proliferation, cell differentiation, and cell survival, which are all critical for tissue repair and regeneration.

The Biomarker Potential of C2CD6

C2CD6 has also been identified as a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This is because the protein is involved in the regulation of cellular processes that are important for the development and progression of these diseases. For example, C2CD6 has been shown to be involved in the regulation of neurogenesis, which is the process by which new neurons are generated in the brain.

In addition, C2CD6 has also been shown to be involved in the regulation of inflammation, which is a critical factor in the development and progression of many diseases, including cancer. The protein has been shown to be involved in the regulation of immune cell function, which is crucial for the immune response to infection and inflammation.

Conclusion

In conclusion, C2CD6 is a protein that has the potential to be a drug target and biomarker. Its unique structure and its involvement in various signaling pathways and cellular processes make it an attractive target for drug development. Additionally, its potential as a biomarker for a variety of diseases makes it an important compound to study further. Further research is needed to fully understand the role of C2CD6 in cellular processes and its potential as a drug and biomarker.

Protein Name: C2 Calcium Dependent Domain Containing 6

Functions: Auxiliary component of the CatSper complex, a complex involved in sperm cell hyperactivation. Sperm cell hyperactivation is needed for sperm motility which is essential late in the preparation of sperm for fertilization. Required for CatSper complex targeting and trafficking into the quadrilinear nanodomains. Targets the preassembled CatSper complexes to elongating flagella, where it links the channel-carrying vesicles and motor proteins

More Common Targets